Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Meister

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Pharmacoepidemiology and Drug Safety|March 5, 2019
Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposureTobias Bluhmki, Anne-Katrin Fietz, Regina Stegherr, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort studyFrank Habermann, Juliane Fritzsche, Frederike Fuhlbrück, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 26, 2018
Safety of diclofenac use during early pregnancy: A prospective observational cohort studyStephanie Padberg, Tatjana Tissen-Diabaté, Katarina Dathe, et al.
Pharmacoepidemiology and Drug Safety|August 4, 2017
Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcomeKatarina Dathe, Stephanie Padberg, Stefanie Hultzsch, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 16, 2018
No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - Evaluation of the national Embryotox cohortKatarina Dathe, Anne-Katrin Fietz, Lucas William Pritchard, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 26, 2018
Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort studyMaria Hoeltzenbein, Tatjana Tissen-Diabaté, Anne-Katrin Fietz, et al.
Steroids|November 27, 2012
Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestinsKlaus Nickisch, Walter Elger, James Cessac, et al.
Pregnancy Hypertension|September 5, 2018
Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort studyMaria Hoeltzenbein, Tatjana Tissen-Diabaté, Anne-Katrin Fietz, et al.
European Journal of Clinical Pharmacology|December 8, 2017
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort studyKatarina Dathe, Stephanie Padberg, Stefanie Hultzsch, et al.
Hypertension (Dallas, Tex. : 1979)|May 24, 2017
Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort StudyMaria Hoeltzenbein, Evelin Beck, Anne-Katrin Fietz, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|March 5, 2019
Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposureTobias Bluhmki, Anne-Katrin Fietz, Regina Stegherr, et al.
Journal of Clinical Psychopharmacology|June 15, 2013
Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort studyFrank Habermann, Juliane Fritzsche, Frederike Fuhlbrück, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 26, 2018
Safety of diclofenac use during early pregnancy: A prospective observational cohort studyStephanie Padberg, Tatjana Tissen-Diabaté, Katarina Dathe, et al.
Pharmacoepidemiology and Drug Safety|August 4, 2017
Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcomeKatarina Dathe, Stephanie Padberg, Stefanie Hultzsch, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 16, 2018
No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - Evaluation of the national Embryotox cohortKatarina Dathe, Anne-Katrin Fietz, Lucas William Pritchard, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 26, 2018
Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort studyMaria Hoeltzenbein, Tatjana Tissen-Diabaté, Anne-Katrin Fietz, et al.
Steroids|November 27, 2012
Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestinsKlaus Nickisch, Walter Elger, James Cessac, et al.
Pregnancy Hypertension|September 5, 2018
Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort studyMaria Hoeltzenbein, Tatjana Tissen-Diabaté, Anne-Katrin Fietz, et al.
European Journal of Clinical Pharmacology|December 8, 2017
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort studyKatarina Dathe, Stephanie Padberg, Stefanie Hultzsch, et al.
Hypertension (Dallas, Tex. : 1979)|May 24, 2017
Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort StudyMaria Hoeltzenbein, Evelin Beck, Anne-Katrin Fietz, et al.
Pageof 4